로슈

주관 임상 단계 분포

• 신약개발2026-07-15

  로슈, 3상 아밀로이드 신약 외 타우 표적 치료제에도 관심 표명

  로슈가 알츠하이머병 치료제 개발에서 임상 3상 단계인 아밀로이드 표적 약물을 주력으로 개발하고 있으나, 타우 단백질을 표적으로 하는 치료 접근법에도 관심을 보이고 있다고 밝혔다. AAIC(알츠하이머병 국제 콘퍼런스)에서 로슈 관계자는 타우 관련 연구 및 개발 옵션을 계속 검토하고 있다고 언급했다. 이는 아밀로이드 단일 표적 전략을 넘어 복합적 병리 기전에 대응하려는 시도로 해석된다.

  Fierce Biotech ↗

진행 중인 임상

• 2상모집 예정협력· Central Serous Chorioretinopathy (CSC)

  Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial

  NCT07681167
• 2상모집 예정협력· Relapsed /Refractory DLBCL

  Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

  NCT07634289
• 2상모집 예정협력· Lymphocytic Leukemia

  Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD

  NCT07566364
• 단계 미표기모집 예정협력· Multiple Sclerosis

  Cognitive Musical Screening and Therapeutic Innovation in Multiple Sclerosis

  NCT07552428
• 2상모집 예정· Obesity or Overweight

  A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight

  NCT07589686
• 1상모집 예정협력· Intracerebral Hemorrhage

  Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)

  NCT06696131
• 2상모집 예정협력· Advanced Lung Non-Small Cell Carcinoma

  SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

  NCT07322341
• 3상모집 예정· Non-small Cell Lung Cancer

  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  NCT07541170
• 3상모집 중· Moderately to Severely Active Crohns Disease

  A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease

  NCT07298421
• 4상모집 예정· Multiple Sclerosis

  A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

  NCT07609719
• 2상모집 예정협력· Acute Myeloid Leukemia

  A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia

  NCT06903702
• 2상모집 예정· Relapsing-remitting Multiple Sclerosis

  A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

  NCT07503340
• 1상모집 예정· Metastatic Colorectal Cancer

  A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

  NCT07416552
• 1상모집 예정· Lupus Erythematosus, Systemic

  To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

  NCT07629583
• 단계 미표기모집 예정· Spinal Muscle Atrophy

  A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA)

  NCT07531719
• 1/2상모집 중· Hemophilia A

  A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

  NCT07226206
• 3상모집 중· Obesity

  A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes

  NCT07670416
• 1상모집 중· Healthy Participants

  A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants

  NCT07626515
• 4상모집 중협력· Presumed Ocular Histoplasmosis

  A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome

  NCT07695298
• 1상모집 중협력· Osteosarcoma

  Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

  NCT06492954